Background Natural products present in low quantity in herb medicines constitute an important source of chemical diversity.However, the isolation of sufficient amounts of these low abundant constituents for structural modification has been a challenge for several decades and subsequently halts research on the utilization of this important source of chemical entities for drug discovery and development.And, pro-angiogenic therapies are being explored as options to treat cardio-cerebral vascular diseases and wound healing recently.